diffuse idiopathic skeletal hyperostosis: This syndrome is characterized by the association of ankylosing vertebral hyperostosis with hyperkeratosis of the soles and palms.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
473 |
4. Check minimum number of eventsNone |
473 |
5. Include endpointsNone |
473 |
6. Filter based on genotype QC (FinnGen only) |
473 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M48
- Name in latin
- Hyperostosis ancylopoetica
Similar endpoints
↥List of similar endpoints to
Ankylosing hyperostosis [Forestier]
based on the number of shared cases.
Similar with more cases:
- Spondylopathies
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3079 | 1249 | 1805 |
| Only index persons | 2836 | 1179 | 1657 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.05 |
| Only index persons | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 58.00 | 58.94 | 57.26 |
| Only index persons | 57.53 | 58.39 | 56.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 473 | 193 | 280 |
| Unadjusted period prevalence (%) | 0.10 | 0.07 | 0.12 |
| Median age at first event (years) | 57.67 | 57.24 | 57.97 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 430
- Matched controls
- 4300
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M48.1
ICD-10 Finland
Ankylosing hyperostosis [Forestier]
4503599627370496.0
323.0
418
*
M48.0
ICD-10 Finland
Spinal stenosis
144.9
141.8
145
15
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
90.8
109.5
119
18
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
902.8
79.0
75
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
56.5
64.0
75
16
N03AX12
ATC
gabapentin; oral
10.0
62.1
136
189
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
31.3
61.4
82
32
N03AX16
ATC
pregabalin; oral
7.4
60.8
170
348
M54.5
ICD-10 Finland
Low back pain
6.4
60.2
200
517
N02AX02
ATC
tramadol; systemic, rectal
5.3
56.9
269
1030
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
9.5
52.7
117
162
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
14.0
51.6
92
82
M54.6
ICD-10 Finland
Pain in thoracic spine
17.6
49.8
80
55
M54.4
ICD-10 Finland
Lumbago with sciatica
10.0
48.7
104
133
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
115.4
47.9
51
5
M54.9
ICD-10 Finland
Dorsalgia, unspecified
13.3
45.7
83
76
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
52.4
43.0
51
11
M47.9
ICD-10 Finland
Spondylosis, unspecified
67.2
42.2
48
8
M47.82
ICD-10 Finland
Other spondylosis, cervical region
35.8
37.5
48
15
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.5
33.2
252
1241
M45
ICD-10 Finland
Ankylosing spondylitis
348.2
32.3
32
*
M01AH05
ATC
etoricoxib; oral
3.4
30.5
296
1705
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
20.3
29.4
44
24
M43.1
ICD-10 Finland
Spondylolisthesis
68.9
28.3
32
5
L03
ICPC
Low back symptom/complaint
4.0
28.1
131
421
M03BX02
ATC
tizanidine; oral
3.2
27.8
291
1714
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
23.7
27.5
39
18
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
55.5
26.6
31
6
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
+∞
24.2
23
*
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
34.4
22.7
29
9
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
66.1
22.1
25
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
26.7
22.1
30
12
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
231.2
21.8
22
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.0
21.8
162
719
M53.1
ICD-10 Finland
Cervicobrachial syndrome
6.2
21.7
61
112
L86
ICPC
Back syndrome with radiating pain
9.3
21.0
44
52
L02
ICPC
Back symptom/complaint
5.7
20.9
63
126
N06AX21
ATC
duloxetine; oral
5.5
20.7
64
132
N02BE01
ATC
paracetamol; systemic, rectal
3.8
20.1
388
3047
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
14.1
20.1
34
26
M54.3
ICD-10 Finland
Sciatica
12.2
19.9
36
32
M01AH02
ATC
rofecoxib; oral
3.9
19.7
88
264
N06AA09
ATC
amitriptyline; systemic
5.2
19.5
64
141
M01AH01
ATC
celecoxib; oral (coxibs)
3.5
19.2
102
351
N02AJ06
ATC
codeine and paracetamol; systemic
2.7
19.1
182
927
M03BC01
ATC
orphenadrine (citrate); systemic
3.2
19.1
115
436
M01AC06
ATC
meloxicam; systemic, rectal
2.7
19.0
186
960
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
18.9
18
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
198.2
18.7
19
*
A02BC05
ATC
esomeprazole; systemic
2.6
18.6
199
1077
M54.1
ICD-10 Finland
Radiculopathy
23.0
18.4
26
12
E66.01
ICD-10 Finland
Obesity due to excess calories
5.6
18.0
54
107
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
21.2
18.0
26
13
M47.81
ICD-10 Finland
Other spondylosis, occipito-atlanto-axial region
69.6
17.9
20
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
4.9
17.6
60
138
N02AA05
ATC
oxycodone; systemic
3.4
17.1
92
317
H02AB06
ATC
prednisolone; systemic
2.4
17.0
228
1370
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
16.8
16
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.8
16.7
127
556
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
176.5
16.6
17
*
M79.6
ICD-10 Finland
Pain in limb
2.6
16.4
160
809
M54.8
ICD-10 Finland
Other dorsalgia
9.7
15.5
31
34
R03AC02
ATC
salbutamol; inhalant
2.3
15.4
226
1394
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
4.8
15.1
51
116
A02BC03
ATC
lansoprazole; oral
2.5
15.1
149
754
M70.6
ICD-10 Finland
Trochanteric bursitis
4.0
14.7
62
175
7216A
ICD-9 Finland
Spondylosis and allied disorders, Ankylosing vertebral hyperostosis
+∞
14.7
14
*
A02BC02
ATC
pantoprazole; systemic
2.3
14.6
289
2034
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.6
14.5
122
560
NF1AA
NOMESCO Finland
Hip X-ray examination
3.9
14.4
61
173
M79.1
ICD-10 Finland
Myalgia
3.8
14.4
63
184
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
14.3
221
1381
M50.3
ICD-10 Finland
Other cervical disc degeneration
44.1
14.2
17
*
M25.5
ICD-10 Finland
Pain in joint
2.6
14.2
129
618
M01AE02
ATC
naproxen; oral, rectal
2.2
14.0
245
1613
A10BA02
ATC
metformin; oral
2.3
13.7
162
885
SPAT1301
SPAT
No procedures
2.3
13.6
158
856
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
13.6
13
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.3
13.4
71
241
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.4
13.3
135
684
G47.3
ICD-10 Finland
Sleep apnoea
2.5
13.3
125
609
C07AB07
ATC
bisoprolol; oral
2.1
13.0
234
1541
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
7.2
12.9
31
46
A06AC01
ATC
ispaghula (psylla seeds); oral
2.5
12.9
118
565
SAA01
NOMESCO Finland
Simple examination of mouth
2.2
12.9
290
2100
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.3
12.8
68
231
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
12.7
142
749
M54.2
ICD-10 Finland
Cervicalgia
6.0
12.7
35
63
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
12.6
150
818
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
+∞
12.6
12
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
12.3
132
682
I10
ICD-10 Finland
Essential (primary) hypertension
2.1
12.2
286
2080
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
4.3
12.1
45
113
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
12.1
107
501
L13
ICPC
Hip symptom/complaint
2.9
12.1
80
316
M01AB05
ATC
diclofenac; systemic, rectal
2.1
12.0
287
2096
SPAT1262
SPAT
Handing over of treatment supplies
2.5
12.0
104
481
M03BC51
ATC
orphenadrine, combinations; systemic
2.4
11.9
122
614
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
11.9
146
805
103
Kela drug reimbursment
Diabetes, insulin-treated
2.2
11.9
151
846
E66.8
ICD-10 Finland
Other obesity
5.3
11.7
35
70
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
66.8
11.7
13
*
M79.0
ICD-10 Finland
Rheumatism, unspecified
10.5
11.6
22
22
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.7
11.6
87
371
M13.9
ICD-10 Finland
Arthritis, unspecified
3.8
11.6
49
139
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
+∞
11.5
11
*
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
11.5
11
*
M43.0
ICD-10 Finland
Spondylolysis
123.2
11.5
12
*
R52.2
ICD-10 Finland
Other chronic pain
8.7
11.4
24
29
A07EC01
ATC
sulfasalazine; oral, rectal
3.8
11.3
49
142
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
13.2
11.2
19
15
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
3.0
11.2
67
246
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.2
11.2
135
734
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.4
11.2
40
97
C08CA01
ATC
amlodipine; oral
2.1
11.2
185
1152
S18
ICPC
Laceration/cut
2.0
11.1
197
1258
M01AX17
ATC
nimesulide; oral
2.3
11.1
123
639
SPAT1153
SPAT
Removal of sutures
2.1
11.1
155
897
J01AA02
ATC
doxycycline; systemic
2.2
11.0
340
2714
205
Kela drug reimbursment
Chronic hypertension
2.1
11.0
155
900
UJF32
NOMESCO Finland
Coloscopy
2.3
11.0
126
666
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
10.9
212
1405
M79.7
ICD-10 Finland
Fibromyalgia
10.0
10.9
21
22
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
10.8
62
222
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.3
10.8
56
187
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
10.6
146
835
M01AE03
ATC
ketoprofen; systemic, rectal
2.1
10.6
170
1036
J01FF01
ATC
clindamycin; systemic
2.2
10.5
123
653
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
+∞
10.5
10
*
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
+∞
10.5
10
*
M01AE01
ATC
ibuprofen; systemic, rectal
2.5
10.4
376
3173
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.6
10.3
79
339
J01DA01
ATC
[U] cefalexin; systemic
1.9
10.0
264
1935
A02BC01
ATC
omeprazole; systemic
2.1
10.0
132
740
M01AX05
ATC
glucosamine; oral
2.3
10.0
109
562
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.9
10.0
225
1556
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.0
9.9
60
222
M84.1
ICD-10 Finland
Nonunion of fracture [pseudarthrosis]
20.6
9.9
14
7
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
7.1
9.7
23
34
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.6
9.7
73
310
T90
ICPC
Diabetes non-insulin dependent
2.1
9.6
126
700
N06AA10
ATC
nortriptyline; systemic
10.4
9.6
18
18
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
4.2
9.6
36
92
B01AB05
ATC
enoxaparin; parenteral
2.0
9.5
148
883
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
102.2
9.4
10
*
M01AC01
ATC
piroxicam; systemic, rectal
2.6
9.3
73
316
R06.0
ICD-10 Finland
Dyspnoea
2.2
9.2
109
578
SPAT1263
SPAT
Sampling
1.9
9.1
183
1199
C10AX09
ATC
ezetimibe; oral
2.7
9.1
66
273
NA2AD
NOMESCO Finland
Thoracic spine CT examination
37.5
9.1
11
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.1
9.0
117
649
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
19.1
9.0
13
7
R03AC03
ATC
terbutaline; inhalant
2.7
9.0
65
268
H02AB07
ATC
prednisone; oral
2.6
9.0
69
297
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
24.6
9.0
12
5
N02AC04
ATC
dextropropoxyphene; oral
5.4
8.9
26
51
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.7
8.9
38
109
K02.1
ICD-10 Finland
Caries of dentine
1.9
8.8
216
1516
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.1
8.8
33
85
SAA02
NOMESCO Finland
Basic examination of mouth
1.8
8.7
243
1777
C10AA07
ATC
rosuvastatin; oral
2.0
8.7
122
697
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.6
8.7
39
117
R05DA20
ATC
opium alkaloids and derivatives - combinations
2.1
8.7
115
642
J01DA08
ATC
[U] cefaclor; oral
3.3
8.6
43
140
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
3.2
8.6
44
146
R53
ICD-10 Finland
Malaise and fatigue
2.3
8.5
85
418
Z50.1
ICD-10 Finland
Other physical therapy
4.1
8.4
32
83
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
8.4
76
355
NAG66
NOMESCO Finland
Posterior interbody fusion of lumbar spine, 2 vertebrae
+∞
8.4
8
*
9211
FHL
Exploration or removal of diskusprolapse
+∞
8.4
8
*
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
+∞
8.4
8
*
J01MA02
ATC
ciprofloxacin; systemic
1.9
8.4
176
1166
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
8.3
191
1298
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.5
8.2
69
308
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.5
8.2
38
117
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
8.2
167
1092
R05FB02
ATC
cough suppressants and expectorants
1.9
8.2
165
1073
A06AD11
ATC
lactulose; oral
2.5
8.1
67
299
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
6.1
8.1
21
36
J01DB01
ATC
cefalexin; oral
2.0
8.1
342
2850
N04BC05
ATC
pramipexole; oral
3.1
8.0
42
143
C10AA01
ATC
simvastatin; oral
1.8
8.0
210
1493
G44.2
ICD-10 Finland
Tension-type headache
2.9
7.9
49
183
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
7.9
59
246
M02AA07
ATC
piroxicam; topical
1.9
7.9
162
1055
KMAK
NOMESCO Finland
NA
1.8
7.9
199
1389
N02AJ13
ATC
tramadol and paracetamol; systemic
9.7
7.8
15
16
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.6
7.8
59
251
M01AB01
ATC
indometacin; systemic, rectal
2.9
7.8
48
179
SFA00
NOMESCO Finland
Small filling
2.6
7.8
59
252
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
7.7
217
1565
A10BJ06
ATC
semaglutide; parenteral
4.8
7.6
24
52
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.1
7.6
95
513
M01AB55
ATC
diclofenac, combinations; oral
3.3
7.5
37
120
L17
ICPC
Foot/toe symptom/complaint
2.0
7.5
108
616
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.5
7.5
25
58
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
7.4
165
1102
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
81.4
7.4
8
*
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
81.4
7.4
8
*
L84
ICPC
Back syndrome without radiat pain
4.4
7.3
25
59
A46
ICD-10 Finland
Erysipelas
2.2
7.3
75
369
WX704
NOMESCO Finland
Intubation
3.3
7.3
36
117
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
4.1
7.3
27
69
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
+∞
7.3
7
*
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
+∞
7.3
7
*
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
+∞
7.3
7
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
7.3
7
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.2
7.3
79
399
L01
ICPC
Neck symptom/complaint
2.6
7.2
53
222
M01AX01
ATC
nabumetone; oral
4.2
7.2
26
65
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
7.2
55
235
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
7.2
164
1101
N06AX16
ATC
venlafaxine; oral
2.6
7.2
52
216
WX110
NOMESCO Finland
Local anesthesy
1.7
7.1
274
2157
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
6.5
7.0
17
27
M77.1
ICD-10 Finland
Lateral epicondylitis
3.5
7.0
31
93
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
3.9
7.0
27
72
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.5
6.9
23
53
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.9
6.9
40
145
R03BA01
ATC
beclometasone; inhalant
2.4
6.9
59
268
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.9
133
844
N06AX11
ATC
mirtazapine; oral
1.8
6.8
125
781
J01EA01
ATC
trimethoprim; systemic
2.0
6.8
93
522
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
40.7
6.8
8
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.1
6.7
35
119
C03CA01
ATC
furosemide; systemic
1.8
6.7
133
849
L08
ICPC
Shoulder symptom/complaint
2.1
6.7
77
399
J01FA06
ATC
roxithromycin; oral
1.8
6.7
165
1128
M53.0
ICD-10 Finland
Cervicocranial syndrome
3.7
6.6
27
76
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
12.5
6.6
11
9
E0000UV
ATC
NA
1.8
6.6
154
1037
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.6
6.6
48
199
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.3
6.5
31
99
M03BB52
ATC
chlormezanone, combinations excl. psycholeptics; oral, rectal
7.6
6.5
14
19
SPAT1058
SPAT
PEF monitoring instruction
2.8
6.4
39
147
P01BA02
ATC
hydroxychloroquine; oral
2.8
6.4
41
158
N06AB04
ATC
citalopram; systemic
2.0
6.4
88
491
M01AE52
ATC
naproxen and esomeprazole; oral
4.7
6.4
20
44
M19.8
ICD-10 Finland
Other specified arthrosis
4.5
6.3
21
49
M01AH03
ATC
valdecoxib; oral
3.0
6.3
34
119
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
+∞
6.3
6
*
NAG65
NOMESCO Finland
Anterior and posterior fusion of lumbar spine
+∞
6.3
6
*
72880
ICD-8 Finland
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
+∞
6.3
6
*
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
+∞
6.3
6
*
L85
ICPC
Acquired deformity of spine
+∞
6.3
6
*
M53.2
ICD-10 Finland
Spinal instabilities
+∞
6.3
6
*
SPAT1216
SPAT
Assessment of functional ability
2.1
6.2
70
359
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.8
6.2
24
65
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.9
6.2
36
132
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.5
6.2
27
81
M15.8
ICD-10 Finland
Other polyarthrosis
7.8
6.2
13
17
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.0
6.2
35
125
A01
ICPC
Pain general/multiple sites
2.9
6.1
35
126
H02AB09
ATC
hydrocortisone; systemic
6.8
6.1
14
21
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
382
2695
3.17
22.75
5.5
3.8
mm/h
13.9
12.8
0.66
362
2447
(3008898) HLA-B27 [Presence]
42
78
5.81
22.07
1.1
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
320
2227
2.35
16.67
5.1
4.7
mmol/l
7.1
6.8
1.01
298
2096
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
116
532
2.56
15.85
1.3
1.2
iu/ml
17.2
38.6
2.46
29
158
(3013650) Neutrophils [#/volume] in Blood by Automated count
303
2099
2.23
15.40
8.6
9.9
e9/l
4.2
4.1
0.34
274
1840
(3037467) Urinalysis macro (dipstick) panel - Urine
342
2491
2.35
15.37
5.1
4.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
108
493
2.54
14.82
1.4
1.2
u/ml
9.4
14.6
0.40
42
192
(3019150) Specific gravity of Urine by Refractometry
140
726
2.32
14.44
5.7
3.5
kg/l
1.0
1.0
0.36
22
109
(3024561) Albumin [Mass/volume] in Serum or Plasma
247
1621
2.10
13.90
5.1
4.9
g/l
36.0
35.2
1.52
232
1508
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
376
2910
2.42
13.78
8.6
7.7
u/l
80.0
79.5
0.09
364
2715
(3001604) Monocytes [#/volume] in Blood
262
1782
2.05
13.11
6.1
5.9
e9/l
0.6
0.6
0.03
232
1530
(3006315) Basophils [#/volume] in Blood
263
1792
2.05
13.08
6.2
5.9
e9/l
0.0
0.0
0.25
233
1548
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
439
3697
3.61
13.08
20.7
14.1
mg/l
20.7
26.6
4.07
384
2906
(3009261) Glucose [Presence] in Urine by Test strip
259
1764
2.03
12.80
4.8
3.3
estimate
0.0
0.0
0.50
34
325
(3019198) Lymphocytes [#/volume] in Blood
265
1823
2.03
12.69
6.3
5.9
e9/l
2.2
2.1
0.05
244
1602
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
247
1688
1.97
11.73
4.9
3.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
183
1128
2.02
11.70
2.3
2.1
u/l
227.9
304.9
0.43
167
1055
(3013115) Eosinophils [#/volume] in Blood
263
1846
1.96
11.44
6.5
6.1
e9/l
0.2
0.2
0.09
243
1619
(3021601) Nitrite [Presence] in Urine by Test strip
252
1748
1.95
11.31
6.3
4.5
estimate
0.0
0.0
0.00
39
342
(3026493) Urate [Moles/volume] in Serum or Plasma
168
1015
2.02
11.28
2.7
2.7
umol/l
8617.1
7077.2
0.14
154
881
(3022217) INR in Platelet poor plasma by Coagulation assay
101
508
2.26
10.89
29.4
23.2
inr
1.1
1.3
3.62
14
77
(3035350) Ketones [Presence] in Urine by Test strip
250
1745
1.92
10.85
4.9
3.3
estimate
0.0
0.0
0.00
39
334
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
208
1375
1.92
10.58
5.3
3.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
276
2003
1.91
10.50
6.1
6.8
umol/l
10.8
12.4
1.54
260
1899
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
216
1466
1.87
9.96
4.3
3.5
ng/l
26.4
50.2
2.78
156
1096
(3048689) Calprotectin [Mass/mass] in Stool
77
359
2.37
9.85
2.0
2.2
ug/g
130.2
149.8
0.34
62
286
(3020682) Albumin/Creatinine [Ratio] in Urine
200
1329
1.87
9.82
4.2
4.1
mg/mmol
7.2
8.1
0.15
151
857
(3031040) Bacteria [#/volume] in Urine by Automated count
313
2396
1.91
9.79
5.9
4.0
e6/l
22.3
3538.7
—
6
44
(3001122) Ferritin [Mass/volume] in Serum or Plasma
213
1448
1.86
9.70
3.5
2.6
ug/l
156.6
156.6
0.00
198
1308
(3019060) Gas panel - Arterial blood
56
228
2.65
9.53
3.9
5.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
342
2714
1.94
9.35
4.6
3.6
pmol/l
15.2
14.9
1.19
322
2420
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
209
1425
1.84
9.33
2.7
2.2
nmol/l
72.9
76.9
1.54
193
1256
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
220
1543
1.80
8.80
2.3
2.0
pmol/l
92.9
95.6
0.33
130
815
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
400
3395
2.15
8.48
5.6
4.3
mu/l
1.8
2.0
2.46
376
3028
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
421
3656
2.38
8.28
8.6
6.0
mmol/mol
42.6
40.4
4.28
402
3354
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
106
602
1.98
8.14
1.8
1.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
225
1616
1.75
8.08
11.1
9.4
inr
1.4
1.3
0.66
57
489
(3042936) Bacteria identified in Isolate by Culture
98
544
2.01
8.02
2.6
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
61
283
2.33
7.85
2.9
2.7
ml/min/173m2
62.2
59.0
0.23
25
106
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
250
1864
1.72
7.74
8.0
6.9
mmol/l
1.2
1.2
0.17
225
1556
(3002030) Lymphocytes/100 leukocytes in Blood
238
1751
1.72
7.73
6.9
6.1
%
28.3
27.0
0.89
216
1636
(3019069) Monocytes/100 leukocytes in Blood
234
1714
1.72
7.72
7.1
6.3
%
8.6
9.0
1.13
217
1618
(3018010) Neutrophils/100 leukocytes in Blood
235
1725
1.72
7.68
6.8
5.9
%
57.4
57.5
0.04
215
1625
(3022948) Iron [Moles/volume] in Serum or Plasma
102
583
1.96
7.66
2.9
2.4
umol/l
12.2
13.0
0.57
95
538
(3009508) Creatinine [Moles/volume] in Urine
186
1282
1.74
7.61
3.4
3.2
mmol/l
8.0
7.9
0.21
162
1060
(3012516) Albumin [Mass/volume] in Urine
182
1250
1.74
7.52
3.4
3.2
mg/l
38.6
156.0
0.94
128
815
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
173
1172
1.75
7.50
3.1
3.1
ng/l
952.4
1383.4
1.44
154
1013
(3026008) Bacteria identified in Urine by Culture
158
1045
1.77
7.44
4.3
2.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
78
410
2.08
7.37
1.8
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
81
432
2.06
7.37
4.9
7.8
mmol/l
2.1
1.2
1.67
63
347
(40760892) CBC W Ordered Manual Differential panel - Blood
123
759
1.84
7.27
6.1
4.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
231
1707
1.69
7.22
6.8
6.0
%
2.8
2.8
0.24
217
1601
(3019550) Sodium [Moles/volume] in Serum or Plasma
445
4017
2.82
7.09
24.0
16.4
mmol/l
139.8
139.7
0.48
438
3895
(3023103) Potassium [Moles/volume] in Serum or Plasma
446
4031
2.86
7.08
24.1
16.6
mmol/l
4.0
4.0
0.83
439
3903
(3014576) Chloride [Moles/volume] in Serum or Plasma
89
498
1.97
7.07
4.8
7.2
mmol/l
103.8
104.3
0.48
89
481
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
409
2.05
7.07
1.8
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
177
1223
1.71
7.06
5.8
5.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
158
1060
1.74
7.00
4.0
4.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
118
732
1.82
6.81
1.8
1.7
mg/l
1.4
1.4
0.01
90
573
(3029937) Albumin [Presence] in Urine by Test strip
145
956
1.75
6.80
5.8
3.4
estimate
0.0
0.0
0.50
38
329
(3011397) Hemoglobin [Presence] in Urine by Test strip
120
759
1.78
6.46
6.0
3.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
172
1208
1.67
6.31
3.7
3.3
u/l
34.1
47.3
0.49
166
1151
(3022096) Basophils/100 leukocytes in Blood
222
1665
1.63
6.27
6.7
6.0
%
0.6
0.7
0.35
207
1564
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
88
511
1.89
6.23
2.8
2.5
%
18.9
23.0
2.18
74
444
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
138
918
1.71
6.19
2.8
2.0
mg/l
3.1
3.1
0.01
124
778
(40761511) CBC panel - Blood by Automated count
435
3928
2.34
6.16
20.5
13.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
76
422
1.95
6.14
2.1
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
91
539
1.85
6.04
3.0
2.5
g/l
2.3
2.3
0.73
82
498
(40761535) Cells panel - Urine sediment
56
280
2.13
6.01
5.3
3.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
90
3.00
5.98
1.4
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
112
709
1.76
5.97
4.3
3.6
ng/l
303.6
422.9
0.37
90
579
(3044640) Blood type and Crossmatch panel - Blood
164
1159
1.64
5.77
3.0
2.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
92
2.93
5.77
1.4
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
29
110
2.74
5.68
1.0
1.1
u/ml
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
94
2.87
5.56
1.4
1.2
—
—
—
0
0
(3020891) Body temperature
33
136
2.53
5.50
3.6
4.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
444
4082
2.43
5.36
14.0
10.4
u/l
27.7
26.6
0.80
435
3914
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
102
2.75
5.34
1.7
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
220
1691
1.56
5.33
6.6
6.0
mmol/l
1.2
1.2
0.86
203
1527
(3015377) Calcium [Moles/volume] in Serum or Plasma
169
1228
1.59
5.20
3.0
3.7
mmol/l
2.4
2.4
0.04
152
1076
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
71
407
1.88
5.20
1.4
1.3
—
—
—
0
0
(3044889) 12 lead EKG panel
332
2811
1.61
5.20
5.0
3.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
179
2.28
5.16
1.5
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
23
81
2.93
5.16
1.0
1.1
—
8.4
—
0
13
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
40
188
2.23
5.01
2.5
2.5
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
105
687
1.68
4.89
1.9
1.7
nmol/l
1134.0
1122.5
0.05
92
520
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
101
2.67
4.89
1.4
1.5
iu/ml
0.0
0.0
—
6
14
(3002032) Base excess in Venous blood by calculation
61
340
1.91
4.86
4.0
3.8
mmol/l
3.4
1.9
1.86
51
266
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
139
2.40
4.80
1.5
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
418
3787
1.89
4.80
6.2
4.7
mmol/l
6.3
6.1
3.10
393
3404
(3037522) Nuclear Ab [Titer] in Serum
74
442
1.80
4.75
1.3
1.3
titre
636.7
368.3
0.28
12
87
(1761482) Bacteria [#/volume] in Urine by Culture
28
115
2.53
4.72
3.5
4.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
103
678
1.66
4.68
1.4
1.2
u/ml
4.0
1.2
0.54
25
187
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
118
809
1.61
4.55
2.0
1.7
pmol/l
104673284.5
6163742.7
0.71
107
649
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
36
171
2.20
4.41
4.1
2.6
%
1.2
1.2
0.14
36
171
(3002385) Erythrocyte distribution width [Ratio]
356
3121
1.57
4.27
23.3
17.6
%
14.0
13.7
1.81
349
3047
(3024354) Oxygen [Partial pressure] in Venous blood
52
290
1.89
4.15
4.3
3.0
kpa
4.6
4.6
0.05
52
279
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
182
1400
1.49
4.11
4.3
3.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
288
2441
1.46
3.85
3.6
3.0
u/l
53.1
57.7
0.55
272
2259
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
254
1.90
3.79
2.0
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
425
3928
1.81
3.76
6.5
5.1
mmol/l
2.6
2.7
1.91
406
3568
(40758558) Short blood count panel - Blood
126
913
1.52
3.74
7.1
7.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
71
452
1.67
3.63
11.6
6.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
7
9
7.87
3.57
1.3
1.8
u/l
259.4
225.6
—
7
9
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
38
202
1.96
3.51
5.6
10.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
98
685
1.54
3.41
3.0
3.3
mmol/l
2.4
2.5
0.54
86
616
(3021960) Folate [Moles/volume] in Serum or Plasma
123
910
1.48
3.26
1.7
1.5
nmol/l
19.4
21.2
0.70
115
757
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
233
1937
1.40
3.24
2.5
2.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
121
895
1.47
3.21
2.7
2.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
51
307
1.74
3.20
6.0
9.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
109
793
1.49
3.13
3.4
2.5
e6/l
2.6
4.7
3.77
93
701
(3003327) Ova and parasites identified in Stool by Light microscopy
23
106
2.23
3.08
1.7
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
208
1708
1.39
3.06
10.6
9.8
e9/l
0.0
0.0
0.46
179
1406
(3018418) pH of Serum or Plasma
145
1121
1.42
3.02
5.1
3.9
ph
7.4
7.4
0.57
21
234
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
30
3.38
2.92
1.5
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
414
3853
1.60
2.88
6.0
4.5
mmol/l
4.4
4.6
2.37
393
3526
(3018095) Leukocytes [#/volume] in Urine
168
1342
1.39
2.88
4.7
3.6
e6/l
24.6
116.4
2.73
126
974
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
58
374
1.63
2.84
1.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
51
319
1.67
2.81
4.3
4.4
%
0.6
1.0
0.78
15
102
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
31
3.27
2.78
2.7
2.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
78
2.36
2.78
3.1
3.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
12
42
2.91
2.77
1.0
1.3
u/l
57.7
48.1
—
6
27
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
411
3828
1.56
2.74
5.7
4.5
mmol/l
1.4
1.4
3.64
388
3475
(21494890) Protein electrophoresis panel - 24 hour Urine
11
37
3.02
2.71
2.2
2.6
—
—
—
0
0
(4010399)
43
260
1.72
2.68
1.4
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
64
429
1.57
2.68
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
65
439
1.56
2.63
3.3
2.7
umol/l
8.2
9.5
0.28
57
391
(3002179) Metamyelocytes/100 leukocytes in Blood
46
285
1.68
2.63
3.8
4.4
%
0.3
0.4
—
8
75
(3041096) Erythrocytes [Presence] in Urine by Automated
129
1001
1.40
2.59
3.6
3.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
20
4.05
2.58
1.5
1.4
nmol/l
114.6
139.1
—
8
20
(3026782) Osmolality of Urine
102
761
1.43
2.55
3.6
2.7
mosm/kgh2o
129.5
571.8
0.52
88
659
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
36
210
1.77
2.55
1.7
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
36
211
1.76
2.51
2.1
2.5
—
14.5
—
0
10
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
96
2.13
2.46
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
117
2.02
2.45
1.9
2.5
ug/min
102.4
68.4
0.20
14
71
(40767503) Oxygen content in Capillary blood by calculation
18
83
2.21
2.44
3.1
2.7
%
17.2
16.4
0.33
12
46
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
398
3705
1.47
2.42
5.3
4.1
mmol/l
1.4
1.3
3.42
377
3347
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
33
191
1.78
2.41
1.2
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
58
2.46
2.39
1.4
1.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
71
2.30
2.37
1.2
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
42
262
1.66
2.36
4.3
4.0
ng/l
108.2
87.4
0.73
37
224
(36660697) Celiac disease serology panel - Serum
36
216
1.72
2.33
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
16
72
2.27
2.30
1.9
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
13
4.66
2.28
18.3
7.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
17
79
2.19
2.27
2.8
3.1
—
—
—
0
0
(3013512) EKG study
150
1216
1.34
2.26
4.7
3.9
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
21
107
2.01
2.24
1.1
1.1
—
1.3
—
0
8
(3000330) Specific gravity of Urine by Test strip
32
188
1.75
2.23
4.2
3.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
13
54
2.45
2.21
1.8
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
61
2.33
2.16
1.4
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
25
3.24
2.10
1.6
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
46
304
1.57
2.07
4.5
4.5
%
0.0
0.1
2.89
14
94
(46235355) HIV 1 and 2 tests - Meaningful Use set
61
430
1.48
2.05
1.3
1.6
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
15
4.04
2.04
1.2
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
26
3.11
2.02
1.6
1.9
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
32
2.85
2.01
1.1
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
39
250
1.61
2.00
2.6
4.1
ph
7.4
7.4
—
8
35
(3000494) Fungus identified in Specimen by Culture
65
467
1.45
1.99
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
64
2.22
1.96
1.4
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
22
120
1.87
1.96
1.5
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
236
1.62
1.94
2.6
4.2
mmol/l
3.2
2.1
0.74
24
183
(3000570) Elastase.pancreatic [Mass/mass] in Stool
19
99
1.96
1.93
1.5
1.4
ug/g
261.3
294.1
0.36
14
59
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
174
1470
1.29
1.90
4.9
4.0
%
19.7
21.5
1.18
87
725
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
15
72
2.12
1.88
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
211
1829
1.28
1.87
5.4
4.7
ug/l
2.2
2.5
0.36
193
1625
(3025159) Blasts/100 leukocytes in Blood
43
287
1.55
1.87
4.7
4.5
%
0.0
1.3
—
9
78
(3028626) Oxygen [Partial pressure] in Capillary blood
18
93
1.97
1.87
2.8
3.2
kpa
8.1
8.0
0.10
18
84
(3020630) Protein [Mass/volume] in Serum or Plasma
46
312
1.53
1.87
3.8
2.7
g/l
67.9
66.5
0.60
41
286
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
17
3.56
1.84
1.2
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
365
3396
1.33
1.83
21.0
15.2
%
38.1
40.2
1.97
224
2332
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
116
1.85
1.81
1.9
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
35
225
1.60
1.79
3.8
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
645
1.37
1.78
3.2
2.8
e6/l
0.8
1.2
1.53
55
373
(3035637) Corticotropin [Mass/volume] in Plasma
9
36
2.53
1.75
1.3
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
46
0.00
1.71
0.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
149
1.72
1.70
1.2
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
141
1179
1.28
1.64
4.3
3.1
e6/l
99.3
124.6
0.11
115
917
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
14
3.60
1.62
1.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
30
191
1.61
1.61
1.2
1.3
—
54.3
—
0
9
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
70
2.03
1.60
1.4
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
38
257
1.52
1.59
2.9
2.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
20
3.02
1.58
1.3
1.8
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
20
3.02
1.58
1.3
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
173
1488
1.26
1.58
2.1
2.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
128
1062
1.28
1.58
4.2
3.1
e6/l
0.3
0.5
1.37
102
801
(21494755) Public health laboratory ask at order entry panel
16
282
0.55
1.55
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
67
509
1.37
1.53
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
392
3713
1.33
1.52
17.4
13.5
ml/min/173m2
77.8
78.1
0.09
347
3083
(3026389) Candida sp identified in Specimen by Organism specific culture
7
27
2.62
1.52
1.1
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
46
328
1.45
1.50
2.8
2.1
nmol/l
14.6
13.5
0.31
38
297
(3024263) Appearance of Synovial fluid
6
22
2.75
1.44
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
299
0.59
1.43
1.8
1.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
60
454
1.37
1.41
2.6
2.8
%
1.6
1.8
1.10
52
410
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
168
1.58
1.34
1.2
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
61
1.99
1.34
1.8
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
61
1.99
1.34
1.8
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
54
2.06
1.34
1.6
2.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
22
137
1.64
1.32
1.2
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
43
2.11
1.31
1.1
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
24
2.52
1.30
2.2
3.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
34
2.38
1.29
1.0
1.1
nmol/l
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
18
2.80
1.29
1.0
1.0
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
5
18
2.80
1.29
3.0
2.4
ug/l
2.2
2.2
—
5
12
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
146
1.60
1.28
1.5
1.8
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
11
55
2.02
1.28
1.6
2.5
mmol/l
3.9
4.0
0.33
11
55
(3035285) Chloride [Moles/volume] in Venous blood
11
55
2.02
1.28
1.6
2.5
mmol/l
106.7
105.0
0.52
11
55
(3010421) pH of Blood
18
107
1.71
1.27
3.5
3.2
ph
7.4
7.4
0.37
13
81
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
35
2.31
1.27
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
25
163
1.56
1.26
1.2
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
36
2.24
1.25
1.0
1.1
nmol/l
2.1
1.5
—
8
31
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
36
2.24
1.25
1.5
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
36
2.24
1.25
1.1
1.2
—
—
—
0
0
(4094501)
18
108
1.69
1.24
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
125
1063
1.24
1.24
1.9
1.6
mmol/l
1.5
1.4
0.96
109
863
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
56
1.99
1.23
1.3
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
49
2.06
1.22
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
19
2.65
1.22
1.4
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
19
2.65
1.22
1.2
2.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
19
2.65
1.22
1.4
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
215
1.47
1.19
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
77
621
1.29
1.19
3.4
2.9
e6/l
1.6
1.8
0.18
49
353
(3004451) EKG impression Narrative
6
26
2.32
1.19
1.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
50
2.02
1.17
1.4
2.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
20
2.52
1.15
1.2
2.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
196
0.55
1.15
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
46
346
1.36
1.15
1.2
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
65
1.87
1.14
1.4
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
126
1453
0.82
1.13
4.2
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
78
636
1.27
1.11
1.3
1.5
g/l
2.7
2.6
0.09
46
401
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
41
1.97
1.09
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
367
1.34
1.09
1.2
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
119
1021
1.22
1.08
4.1
3.0
—
—
—
0
0
(4035726)
28
393
0.69
1.08
1.1
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
179
1.48
1.05
1.1
1.2
iu/ml
206.4
134.0
—
9
74
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
47
1.93
1.02
1.7
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
47
1.93
1.02
1.7
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
47
1.93
1.02
1.7
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
53
1.91
1.02
2.2
2.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
31
223
1.42
1.01
3.4
2.9
e9/l
4.6
4.1
0.73
25
168
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
48
1.89
1.01
1.7
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
48
1.89
1.01
1.7
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
48
1.89
1.01
1.7
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
76
1.73
1.00
1.6
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
92
1.65
0.98
1.5
2.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
157
1.49
0.98
1.8
1.9
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
30
0.00
0.97
0.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
62
1.79
0.95
2.9
2.5
e9/l
3.4
4.3
1.04
11
62
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
11
64
1.74
0.87
3.9
2.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
80
1.64
0.85
1.4
1.9
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
32
1.89
0.82
1.5
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
47
1.71
0.81
1.8
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
58
1.74
0.80
1.2
1.9
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
25
2.01
0.73
1.0
7.0
—
40.0
—
0
6
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
25
2.01
0.73
1.2
1.4
—
74.3
—
0
7
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
68
1.63
0.72
2.9
2.9
%
51.3
56.8
0.88
11
68
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
349
1.26
0.68
2.4
2.2
u/l
40.7
43.4
0.06
38
307
(3045414) Leukocytes [Presence] in Urine
20
145
1.40
0.67
1.5
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
127
0.62
0.65
1.0
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
95
1.49
0.64
5.1
4.0
mg/l
16.0
34.0
—
8
60
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
254
1.28
0.61
1.6
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
41
337
1.24
0.59
1.9
3.0
e9/l
64.0
69.3
0.47
36
263
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
132
1.38
0.58
2.3
2.8
u/ml
0.2
0.4
—
10
71
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
50
423
1.20
0.56
4.0
3.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
65
1.55
0.56
1.2
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
82
1.48
0.55
1.8
1.6
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
39
1.55
0.53
1.3
2.9
nmol/l
3.9
3.9
—
6
39
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
6
40
1.51
0.51
1.0
1.3
pmol/l
208.5
319.7
—
6
35
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
92
1.42
0.51
1.5
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
65
1.39
0.51
1.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
65
1.39
0.51
1.2
1.2
—
—
—
0
0
(4024509)
6
41
1.47
0.50
2.2
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
10
67
1.50
0.50
1.0
1.2
e6/l
2.0
58.2
—
10
54
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
10
67
1.50
0.50
1.1
1.3
e6/l
130.4
163.5
—
10
55
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
81
0.61
0.46
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
103
1.37
0.45
1.4
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
148
1.30
0.44
2.4
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
95
1.38
0.44
4.0
3.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
27
326
0.82
0.42
4.7
3.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
10
70
1.44
0.42
1.2
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
10
70
1.44
0.42
1.1
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
105
1.34
0.41
1.4
1.8
—
—
—
0
0
(4062490)
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
35
297
1.19
0.40
3.0
2.6
g/l
10.1
10.7
0.33
35
276
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
34
1.48
0.40
2.0
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
61
1.32
0.39
1.9
2.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
8
61
1.32
0.39
1.4
1.2
u/l
7.7
9.1
—
8
51
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
69
1.31
0.37
1.3
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
37
1.36
0.37
5.8
3.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
72
1.40
0.37
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
81
1.37
0.36
1.6
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
1.3
2.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
45
1.34
0.34
3.2
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
111
1.27
0.30
1.6
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
84
1.32
0.30
1.3
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
102
1.28
0.30
1.5
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
148
1.22
0.29
2.9
1.9
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
57
1.23
0.29
1.3
1.1
%
118.0
111.8
—
7
52
(4306422)
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
520
0.89
0.27
5.0
4.6
%
30.1
31.4
0.40
39
337
(4034850)
15
122
1.24
0.27
18.1
7.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
72
1.25
0.25
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
30
339
0.88
0.25
1.4
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
87
1.27
0.24
3.7
7.0
—
252.5
—
0
11
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
42
1.19
0.21
2.0
2.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
114
1086
1.07
0.21
3.1
2.9
ug/l
0.6
0.8
3.24
79
741
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
2.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
11
0.00
0.21
0.0
2.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
43
1.16
0.21
2.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
1489.4
—
0
13
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
14
117
1.20
0.20
2.5
2.5
g/l
3.4
3.8
0.44
14
109
(3028026) IgM [Mass/volume] in Serum or Plasma
27
240
1.13
0.20
1.3
1.9
g/l
0.9
1.6
2.63
27
223
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
14
0.00
0.20
0.0
1.1
—
15.7
—
0
7
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
12
100
1.21
0.18
1.2
2.2
mg/l
16.1
12.7
0.69
12
91
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
18
157
1.15
0.17
1.6
2.1
u/l
41.2
38.0
0.28
18
138
(3052851) Hemolysis interference index of Serum or Plasma
13
110
1.19
0.17
3.5
3.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
68
0.73
0.17
13.6
2.7
%
55.6
64.9
—
5
68
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
111
1.18
0.16
1.5
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
149
1.15
0.16
1.0
1.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
99
1027
0.95
0.13
1.5
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
126
0.87
0.11
1.1
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
183
1.10
0.10
2.2
4.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
5
45
1.11
0.10
2.0
1.2
—
—
—
0
0
(44790049)
5
46
1.09
0.09
1.2
1.8
—
—
—
0
0
(44790047)
5
46
1.09
0.09
1.2
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
46
1.09
0.09
1.4
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
46
1.09
0.09
2.0
1.2
—
—
—
0
0
(44790048)
5
46
1.09
0.09
1.2
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
5
46
1.09
0.09
2.0
1.2
—
—
—
0
0
(44806118)
5
46
1.09
0.09
1.2
1.8
—
—
—
0
0
(4146454)
5
47
1.06
0.09
2.8
2.9
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
47
1.06
0.09
2.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
20
184
1.09
0.09
3.1
3.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
48
459
1.05
0.09
4.0
4.8
ug/l
5.7
33.7
0.98
39
387
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
54
1.11
0.09
1.3
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
37
351
1.06
0.09
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
88
1.14
0.08
1.1
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
64
1.10
0.08
3.0
2.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
85
0.82
0.07
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
17
157
1.09
0.07
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
85
1.06
0.07
11.9
2.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
91
0.88
0.07
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
91
0.88
0.07
1.0
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
14
151
0.92
0.05
3.5
3.4
g/l
0.2
0.2
—
5
62
(3002256) Pathology report gross observation
49
504
0.97
0.04
1.1
1.3
—
—
—
0
0
(3019225) pH of Specimen
39
382
1.02
0.01
4.1
4.7
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
124
1.05
0.00
2.2
2.2
%
95.6
88.1
0.63
13
116
(3021879) Hepatitis B virus core Ab [Presence] in Serum
23
228
1.01
0.00
1.0
1.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
9
94
0.96
0.00
3.3
2.9
umol/l
41.4
49.1
—
9
84
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
6
0.00
0.00
0.0
1.5
—
127.2
—
0
6
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
16.9
—
0
6
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
5.6
—
5.9
—
0
5
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
58
0.86
0.00
2.0
2.6
pg
32.4
32.6
—
5
58
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
1.0
1.1
g/l
1.6
1.5
—
6
55
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4198724)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
8
83
0.96
0.00
1.6
2.1
—
6.4
—
0
25
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
120
1.00
0.00
2.2
1.6
nmol/l
35.8
40.9
0.82
12
115
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
22.2
—
0
5
(4015189)
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
64
0.94
0.00
1.0
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
18.3
—
0
7
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
63
0.95
0.00
1.2
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_FORESTIER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_FORESTIER | 1.208 [1.03, 1.42] | 0.021 |
| Birth year | 0.99 [0.98, 1.0] | 0.023 |
During the follow-up period (1.1.1998 — 31.12.2019), 210 out of 1048 females with M13_FORESTIER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_FORESTIER | 1.194 [1.04, 1.37] | 0.012 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 338 out of 1527 males with M13_FORESTIER died.
Mortality risk
Mortality risk for people of age
years, who have M13_FORESTIER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.069% | 0.213% |
| 5 | 0.511% | 1.204% |
| 10 | 1.405% | 3.308% |
| 15 | 2.672% | 6.12% |
| 20 | 4.768% | 10.485% |
Relationships between endpoints
↥Index endpoint: M13_FORESTIER – Ankylosing hyperostosis [Forestier]
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data